Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Ethionamide-induced gynecomastia

    Ramakant Dixit1★, Jacob George1, Arun K. Sharma2, Naveen chhabra2, Suresh K. Jangir1, Vikas Mishra1★ Corresponding author

    1. 1Departments of Respiratory Medicine, College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.
    2. 2Pharmacology and Experimental Therapeutics, J. L. N. Medical College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.

    CORRESPONDENCE

    Ramakant Dixit

    Departments of Respiratory Medicine, College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.

    Volume 3, Issue 2 · pp. 196–199 · PUBLISHED 2012 · DOI: 10.4103/0976-500X.95532

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Dixit, R., George, J., Sharma, A. K., chhabra, N., Jangir, S. K., & Mishra, V. (2012). Ethionamide-induced gynecomastia. Journal of Pharmacology and Pharmacotherapeutics, 3(2), 196–199. https://doi.org/10.4103/0976-500X.95532